Viewing Study NCT06359353



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06359353
Status: COMPLETED
Last Update Posted: 2024-04-11
First Post: 2024-04-01

Brief Title: Effect of Pitavastatin on Bone
Sponsor: Seoul National University Bundang Hospital
Organization: Seoul National University Bundang Hospital

Study Overview

Official Title: Effect of Pitavastatin on Bone Metabolism in Patients With Hypercholesterolemia and Low Bone Mass
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This clinical trial investigates the effects of pitavastatin on bone health in postmenopausal women with osteopenia or osteoporosis and hypercholesterolemia Given the high prevalence of osteoporosis in aging populations and the associated risks even with existing treatments this study addresses a critical gap in medical research Statins specifically HMG-CoA reductase inhibitors are suggested to benefit bone metabolism by promoting bone formation and reducing resorption However the specific impact of pitavastatin on bone metabolism lacks clinical evidence

The studys primary goal is to determine the effects of a 12-month pitavastatin regimen on bone metabolism markers in this population This research could significantly contribute to developing more effective osteoporosis treatments for postmenopausal women combining bone health and cholesterol management strategies
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None